Drugs / FLUAD Pediatric
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03698279 Comparator | Oct 2018 → Oct 2019 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUAD Pediatric | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03698279 ↗ |
| Modality | Vaccine | “adjuvanted trivalent influenza vaccine (aIIV3, 7.5 µg HA/strain)” PMID 33610374 ↗ Feb 2021 |
| Route | Intramuscular | “Route of administration: IM” NCT03698279 ↗ |